Who is sponsoring NCT02774135?

NCT02774135 is sponsored by Clalit Health Services.

What drugs are being tested in NCT02774135?

Interventions in NCT02774135: direct occupational therapy intervention.

What condition does NCT02774135 study?

NCT02774135 studies Limited Participation in Daily Life Activities.

Is NCT02774135 still recruiting?

NCT02774135 is currently completed. Last updated 21 April 2021.

Last reviewed 2021-04-21 · How we verify

NCT02774135

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Improvement in Preschoolers' Participation as a Result of Occupational Therapy Intervention

Completed Last updated 21 April 2021

What this trial tests

trial testing direct occupational therapy intervention in Limited Participation in Daily Life Activities in 52 participants. Completed in 19 April 2021.

Timeline

1 May 2017

Primary endpoint
31 October 2020

19 April 2021

Quick facts

Lead sponsor	Clalit Health Services
Status	Completed
Study type	OBSERVATIONAL
Enrollment	52
Start date	1 May 2017
Primary completion	31 October 2020
Estimated completion	19 April 2021
Sites	1 location across Israel

Drugs / interventions tested

direct occupational therapy intervention

Conditions studied

Limited Participation in Daily Life Activities — all drugs for Limited Participation in Daily Life Activities →

Sponsor

Clalit Health Services — full company profile →

Who can join

Adults 54 Months to 83 Months, any sex, with Limited Participation in Daily Life Activities. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the improvement of participation in everyday occupation among preschool children with mild developmental disabilities as a result of Occupational Therapy intervention.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The Effect of a Short-Term Occupational Therapy Intervention on the Participation and Personal Factors of Preschoolers with Developmental Disabilities.
Soref B, Robinson GL, Bart O. · · 2023 · cited 3× · PMID 37628400 · DOI 10.3390/children10081401

Verify or expand the search:

Other Clalit Health Services trials

Trials by the same sponsor.

NCT04709003 — Covid-19 Vaccine Effectiveness in Healthcare Personnel in Clalit Health Services in Israel (CoVEHPI) · completed
NCT04228159 — Perturbation Training Compared to Balance and Strengthening Exercise, for Elderly at Risk of Falling · NA · unknown
NCT03973658 — Dizziness Among First Time Users of Hearing Aids · unknown
NCT03867019 — The Cardiac Autonomic Control System Response to Vestibular Stimulation in Subjects With and Without BPPV · completed
NCT03821220 — Improving Physical Activity Levels in the Arabic- Speaking Residents of East Jerusalem With Prediabetes · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02774135 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Clalit Health Services
Last refreshed: 21 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02774135.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing